Author:
Saeed Mohamed,Jacob Stefan,Sandjo Louis P.,Sugimoto Yoshikazu,Khalid Hassan E.,Opatz Till,Thines Eckhard,Efferth Thomas
Subject
Pharmacology (medical),Pharmacology
Reference86 articles.
1. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.;Agarwal;Proc. Natl. Acad. Sci. U.S.A.,1995
2. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.;Bai;Int. J. Cancer,2009
3. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance.;Barancík;Eur. J. Pharm. Sci.,2006
4. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.;Boyer;Clin. Cancer Res.,2004
5. Activity of pp60c-src in 60 different cell lines derived from human tumors.;Budde;Cancer Biochem. Biophys.,1994
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献